Convulex CR 500 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

convulex cr 500 mg

g.l. pharma gmbh, rakúsko - kyselina valproová - 21 - antiepileptica, anticonvulsiva

Rediema Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rediema

idelyn s.r.o. - iné antidepresíva - 92 - tradiČnÉ rastlinnÉ lieky

Epidyolex Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

epidyolex

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptiká, - epidyolex je indikovaný na použitie ako adjunctive terapie záchvaty spojené s lennox gastaut syndróm (lgs) alebo dravet syndróm (ds), v spojení s clobazam, pre pacientov 2 rokov a starší.

Lumeblue (previously known as Methylthioninium chloride Cosmo) Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metyltioníniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Byfavo Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

byfavo

paion deutschland gmbh - remimazolam besilate - vedomie sedácie - psycholeptika - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

Trodelvy Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

trodelvy

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastické činidlá - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Trobalt Kesatuan Eropah - Slovak - EMA (European Medicines Agency)

trobalt

glaxo group limited  - retigabin - epilepsie - antiepileptiká, - trobalt je indikovaný ako prídavná liečba záchvatov čiastočného nástupu rezistentných voči lieku so sekundárnou generalizáciou alebo bez nej u pacientov vo veku 18 rokov alebo starších s epilepsiou, kde iné vhodné kombinácie liekov sa ukázali ako nedostatočné alebo neboli tolerované.